Royal Bank of Canada
AST.WS

Royal Bank of Canada’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Royal Bank of Canada’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-9
Closed – – 7397
2017
Q2 		$0 Buy
9
+1
+13% – ﹤0.01% 7150
2017
Q1 		$0 Hold
8
– – ﹤0.01% 7097
2016
Q4 		$0 Hold
8
– – ﹤0.01% 7030
2016
Q3 		$0 Sell
8
-26
-76% -$7 ﹤0.01% 6878
2016
Q2 		$0 Buy
+34
New +$18 ﹤0.01% 6851

Royal Bank of Canada's AST.WS Position: Q3 2017 in Review

Royal Bank of Canada sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 9 shares.

Royal Bank of Canada first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • Royal Bank of Canada reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • Royal Bank of Canada sold 9 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017.
  • Royal Bank of Canada first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
  • Royal Bank of Canada's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on Royal Bank of Canada's 13F filing for Q3 2017, filed 14 Nov 2017.